Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Protein orai-1 | 0.5492 | 1 | 1 |
Schistosoma mansoni | Protein orai-1 | 0.5492 | 1 | 1 |
Echinococcus granulosus | calcium release activated calcium channel | 0.5492 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.5492 | 1 | 1 |
Echinococcus multilocularis | calcium release activated calcium channel | 0.5492 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | < 50 ug | Antifungal activity against Cryptococcus neoformans ATCC 28952 assessed as concentration required to inhibit fungal growth after 24 hrs by TLC assay | ChEMBL. | 23819826 |
Activity (functional) | < 50 ug | Antifungal activity against Candida albicans ATCC 10231 assessed as concentration required to inhibit fungal growth after 24 hrs by TLC assay | ChEMBL. | 23819826 |
Activity (functional) | < 50 ug | Antifungal activity against Saccharomyces cerevisiae ATCC 2601 assessed as concentration required to inhibit fungal growth after 24 hrs by TLC assay | ChEMBL. | 23819826 |
Activity (functional) | < 50 ug | Antibacterial activity against Escherichia coli ATCC 11103 assessed as concentration required to inhibit bacterial growth after 24 hrs by TLC assay | ChEMBL. | 23819826 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.